28
Views
7
CrossRef citations to date
0
Altmetric
Review Papers

Pituitary Incidentaloma: to Operate or Not to Operate ?

&
Pages 255-260 | Published online: 11 Mar 2016

References

  • Marie P. Sur deux cas d’acromégalie. Hypertrophie singulière non congénitale des extrémités supérieures, inférieures et céphaliques. Rev. Med.1885/1886, 6: 297–333.
  • Molitch M. E. Pituitary incidentalomas. Best Pract Res Clin Endocrinol Metab, 2009, 23: 667–675.
  • Peyster R. G., Adler L. P., Viscarello R. R. et al. CT of the normal pituitary gland. Neuroradiology, 1986, 28: 161–165.
  • Chamber E. F., Turski P. A., LaMasters D. et al. Regions of low density in the contrast-enhanced pituitary gland: normal and pathological processes. Radiology, 1982, 144: 109–113.
  • Hall W. A., Luciano M. G., Doppman J. L., Patronas N. J., Oldfield E. H. Pituitary magnetic resonance imaging in normal human volunteers: occult adenomas in the general population. Ann Intern Med, 1994, 120: 817–820.
  • Chong B. W., Kucharczyk A. W., Singer W. et al. Pituitary gland MR: a comparative study of healthy volunteers and patients with microadenomas. Am J Neuroradiol, 1994, 15: 675–679.
  • Nammour G. M., Ybarra J., Hossain N., Romeo J., Aron D. Incidental pituitary macroadenoma: a population-based study. Am J Med Sci, 1997, 314: 287–291.
  • Yue N. C., Longstreth W. T., Elster A. D., Jungreis e. A., O’Leary D. H., Poirier V. C. Clinically serious abnormalities found incidentally at MR imaging of the brain: data from the cardiovascular health study. Radiology, 1997, 202: 41–46.
  • Vernooij M. W., Ikram M. A., Tanghe H. L. et al. Incidental findings on brain MRI in the general population. N Engl J Med, 2007, 357: 1821–1828.
  • Sanno N., Oyama K., Tahara S., Teramoto A., Kato Y. A survey of pituitary incidentaloma in Japan. Eur J Endocrinol, 2003, 149: 113–127.
  • Buurman H., Saeger W. Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur J Endocrinol, 2006, 154: 753–758.
  • Feldkamp J., Santen R., Harms E., Aulich A., Mödder U., Scherbaum W. A. Incidentally discovered pituitary lesions: high frequency of macroadenomas and hormone-secreting adenomas - results of a prospective study. Clin Endocrinol, 1999, 51: 109–113.
  • Fainstein Day P, Guitelman M., Artese R. et al. Retrospective multicentric study of pituitary incidentalomas. Pituitary, 2004, 7: 145–148.
  • Reincke M., Allolio B., Saeger W., Menzel J., Winkelman W. The ‘incidentaloma’ of the pituitary gland. Is neurosurgery required ? JAMA, 1990, 263: 2772–2776.
  • Donovan L. E., Corenblum B. The natural history of the pituitary incidentaloma. Arch Intern Med, 1995, 155: 181–183.
  • Yuen K. C., Cook D. M., Sahasranam P. et al. Prevalence of GH and other anterior pituitary hormone deficiencies in adults with nonsecreting pituitary microadenomas and normal IGF-1 levels. Clin Endocrinol, 2008, 69: 292–298.
  • Igarashi T., Saeki N., Yamura A. Long-term magnetic resonance imaging follow-up of asymptomatic sellar tumors. Their natural history and surgical indications. Neurologia Medico-Chirugica, 1999, 39: 592–594.
  • Chanson P., Daujat F., Young J. et al. Normal pituitary hypertrophy as a frequent cause of pituitary incidentaloma: a follow-up study. J Clin Endocrinol Metab, 2001, 86: 3009–3015.
  • Fernandez-Balsells M. M., Murad M. H., Barwise A. et al. Natural history of nonfunctioning pituitary adenomas and inciden-talomas: a systematic review and metaanalysis. J Clin Endocrinol Metab, 2011, 96: 905–912.
  • FredaP F., Beckers A., Katznelson L. et al. Pituitary incidentaloma: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011, 96: 894–904.
  • Karavitaki N., Ansorge O., Wass J. A. Silent corticotroph adenomas. Arq Bras Endocrinol Metabol, 2007, 51: 1314–1318.
  • Angeli A., Terzolo M. Adrenal incidentaloma - a modern disease with old complications. J Clin Endocrinol Metab, 2002, 87: 48694871.
  • Caroll T., Raff H., Findling J. W. Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis. Endocr Pract, 2009, 15: 335–342.
  • Melmed S., Casanueva F. F., Hoffman A. R. et al. Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab, 2011, 96: 273–288.
  • Leite V., Cosby H., Sobrinho L. G. et al. Characterization of big, big prolactin in patients with hyperprolactinaemia. Clin Endocrinol, 1992, 37: 365–372.
  • Karavitaki N., Thanabalasingham G., Shore H. C. et al. Do the limits of serum prolactin in disconnection hyperprolactinaemia need re-definition ? A study of 226 patients with histologically verified non-functioning pituitary macroadenoma. Clin Endo-crinol, 2006, 65: 524–529.
  • St Jean E., Blain F., Comtois R. High prolactin levels may be missed by immunoradiometric assay in patients with macro-prolactinoma. Clin Endocrinol, 1996, 44: 305–309.
  • Arafah A. M. Reversible hypopituitarism in patients with large nonfunctioning pituitary adenomas. J Clin Endocrinol Metab, 1986, 62: 1173–1179.
  • Dekkers O. M., Hammer S., de Keizer R. J. W. et al. The natural course of non-functioning pituitary macroadenomas. Eur J Endocrinol, 2007, 156: 217–224.
  • Karavitaki N., Collison K., Halliday J. et al. What is the natural history of nonoperated nonfunctioning pituitary adenomas ? Clin Endocrinol, 2007, 67: 938–943.
  • Freda P, Katznelson L., Molitch M. The Hormone Foundation’s patient guide to pituitary incidentaloma assessment and treatment. J Clin Endocrinol Metab, 2011, 96: 35A-36A.
  • Greenman Y., Tordjman K., Ocher E. et al. Postoperative treatment of clinically nonfunctioning pituitary adenomas with dopamine agonists decreases tumour remnant growth. Clin Endocrinol, 2005, 63: 39–44.
  • ColaoA., Di Somma C., PivonelloR., FaggianoA., Lombardi G., Savastano S. Medical therapy for clinically non-functioning pituitary adenomas. Endocr Relat Cancer, 2008, 15: 905–915.
  • Andersen M., Bjerre P, Schroder H. D. et al. In vivo secretory potential and the effect of combination therapy with octreotide and cabergoline in patients with clinically non-functioning pituitary adenomas. Clin Endocrinol, 2001, 54: 23–30.
  • Sassolas G., Lejeune H., Trouillas J. et al. Gonadotrophin-releasing hormone agonists are successful in tumoral gonado-trophin secretion in two patients with gonadotrophin-secreting adenomas. J Clin Endocrinol Metab, 1988, 67: 180–185.
  • Klibanski A., Jameson J. L., Biller B. M. et al. Gonadotrophin and alpha-subunit responses to chronic gonadotrophin-releasing hormone analog administration in patients with glycoprotein hormone-secreting pituitary tumours. J Clin Endocrinol Metab, 1989, 68: 81–86.
  • McGrath G. A., Goncalves R. J., Udupa J. K. et al. New techniques for quantification of pituitary adenoma size: use in evaluating treatment of gonadotroph adenomas with a gonado-trophin-releasing hormone antagonist. J Clin Endocrinol Metab, 1993, 76: 1363–1368.
  • Gittoes NJL. Pituitary radiotherapy: current controversies. Trends in Endocrinology and Metabolism, 2005, 16: 407–413.
  • Chanson P., Brochier S., Salenave S. Adénomes hypophysaires non fonctionnels et adénomes gonadotropes. In: Chanson P. and Young J. (eds.). Traité d’Endocrinologie. Paris, Médecine- Sciences Flammarion, 2007: 943–949.
  • Greenman Y., QuaknineG., VeshchevI., Reider-Grosswasser I. I., Segev Y., Stern N. Postoperative surveillance of clinically nonfunctioning pituitary macroadenomas: markers of tumour quiescence and regrowth. Clin Endocrinol, 2003, 58: 763–769.
  • Greenman Y., Stern N. Non-functioning pituitary adenomas. Best Pract Res Clin Endocrinol Metab, 2009, 23: 625–638.
  • Park P., Chandler W. F., Barkan A. L., Orrego J. J., Cowan J. A., Griffith K. A., Tsien C. The role of radiation therapy after surgical resection of non-functional pituitary macroadenomas. Neuro-surgery, 2004, 55: 100–106.
  • Randall B. R., Kraus K. L., Simard M. F., Couldwell W. T. Cost of evaluation of patients with pituitary incidentaloma. Pituitary, 2010, 13: 383–384.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.